Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
* Core operating profit of $566 mln vs consensus of $574 mln* 2021 outlook weaker than analyst expectation* Shares drop nearly 7% (Recasts, adds shares, CEO and analyst comments)By Tanishaa Nadkar and Pushkala AripakaFeb 25 (Reuters) - Hikma Pharmac...
Read more
LONDON MARKET PRE-OPEN: ABF's Primark Loses GBP1.1 Billion In Sales
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreBROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...
Read more
(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.
Read moreTOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia
Read moreVectura Forecasts 2020 Earnings To Top Board Expectations
Read moreLONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
Read moreLONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
Read moreUK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
Read more(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
Read moreHikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Read more(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.
Read more(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.
Read more
Last checked at